Annexon biosciences to present at the jefferies london healthcare conference

Brisbane, calif., nov. 13, 2024 (globe newswire) -- annexon, inc. (nasdaq: annx), a biopharmaceutical company focused on upstream c1q to advance therapies for neuroinflammatory diseases of the body, brain and eye, today announced that douglas love, president and chief executive officer, will present at the jefferies london healthcare conference on wednesday, november 20, 2024 at 10:30 a.m. gmt.
ANNX Ratings Summary
ANNX Quant Ranking